Nuclearelectrica, Romania’s sole nuclear power producer, ended the first nine months of 2025 with RON4.1 billion operating revenues, up 23% from the year-earlier level, while net profit rose by 26.6% to RON1.63 billion.
Private healthcare provider MedLife reported pro-forma consolidated turnover worth above RON2.36 billion in the first nine months of 2025, up 19.5% from the year-earlier period.
Digi Communications, a telecom group listed on the Bucharest Stock Exchange, for the first nine months of 2025 reported EUR1.64 billion consolidated revenues, up 16% from the year-earlier period, supported by the expanding portfolio of clients on all the markets it operates on-Romania, Spain, Portugal and Spain.
Transgaz ended the first nine months of 2025 with consolidated net profit of RON682 million, up 471% from the year-earlier period, amid rising regulated revenues and a significant contribution from financial activity.
State-owned Romgaz, a natural gas producer and supplier, ended the first nine months of 2025 with rising financial results in a context of slightly higher natural gas national consumption and significant electricity output adjustments.
Taffo, a Baia Mare-based builder owned by three Romanian shareholders, for 2024 reported turnover of around RON87.5 million (EUR17.6 million), down 26.2% from 2023, in line with ZF calculations based on Finance Ministry data.
Türkiye’s Tosmur Group, which owns a starch plant in Medgidia, inaugurated in 2022, will complete construction of a new facility, which will double the production capacity, following a EUR86 million investment.
Grain trader and seed supplier Soufflet Agro Romania, which is part of the French Soufflet group, posted RON246.5 million (EUR49.5 million) revenue in 2024, up 13.3% from the previous year’s RON217.5 million (approximately EUR44 million), according to ZF calculations based on Finance Ministry data.
Antibiotice Iasi's net profit fell by 52% to RON42.6 million in the first nine months of 2025, from RON87.9 million in the same period last year, the pharmaceutical manufacturer said in its latest financial report.